| 
		Sri Lankan medicine shortage a death sentence for some, doctors say
		 Send a link to a friend 
		
		 [May 23, 2022] 
		By Sunil Kataria 
 COLOMBO (Reuters) - A shortage of medicine 
		caused by an economic crisis in Sri Lanka could soon cause deaths, 
		doctors said, as hospitals are forced to postpone life-saving procedures 
		for their patients because they do not have the necessary drugs.
 
 Sri Lanka imports more than 80% of its medical supplies but with foreign 
		currency reserves running out because of the crisis, essential 
		medications are disappearing from shelves and the healthcare system is 
		close to collapse.
 
 At the 950-bed Apeksha cancer hospital on the outskirts of the 
		commercial capital, Colombo, patients, their loved ones and doctors feel 
		increasingly helpless in the face of the shortages which are forcing the 
		suspension of tests and postponement of procedures including critical 
		surgery.
 
 "It is very bad for cancer patients," said Dr Roshan Amaratunga.
 
 "Sometimes, in the morning we plan for some surgeries (but) we may not 
		be able to do on that particular day ... as (supplies) are not there."
 
		
		 
		If the situation does not improve quickly, several patients would be 
		facing a virtual death sentence, he said.
 Sri Lanka is grappling with its most devastating economic crisis since 
		independence in 1948, brought about by COVID-19 battering the 
		tourism-reliant economy, rising oil prices, populist tax cuts and a ban 
		on the import of chemical fertilisers, which devastated agriculture.
 
 A government official working on procuring medical supplies, said about 
		180 items were running out, including injections for dialysis patients, 
		medicine for patients who have undergone transplants and certain cancer 
		drugs.
 
 The official, Saman Rathnayake, told Reuters that India, Japan and 
		multilateral donors were helping to provide supplies, but it could take 
		up to four months for items to arrive.
 
 In the meantime, Sri Lanka has called on private donors, both at home 
		and abroad, for help, he said.
 
 'TREMENDOUS FEAR'
 
 Doctors say they are more worried than the patients or their relatives, 
		as they are aware of the gravity of the situation and the consequences.
 
 
		[to top of second column] | 
            
			 
            
			Essential supplies of rice, milk and some critically needed 
			medicines are pictured inside a cargo ship, which arrived from 
			India, amid Sri Lanka's economic crisis, at a port in Colombo, Sri 
			Lanka, May 22, 2022. Picture taken May 22, 2022. REUTERS/Adnan Abidi 
            
			
			
			 Referring to the ubiquitous queues 
			for petrol and cooking gas, Dr Vasan Ratnasingam, a spokesman for 
			the Government Medical Officers' Association, said the consequences 
			for people awaiting treatment were so much more dire.
 "If patients are in a queue for drugs, they will lose their lives," 
			said Ratnasingam.
 
 The mother of Binuli Bimsara, a four-year-old girl being treated for 
			leukaemia, said she and her husband were terrified.
 "Earlier, we had at least some hope because we had 
			the medication but now we are living under tremendous fear," the 
			mother said. 
 "We are really helpless, our future is really dark when we hear 
			about a shortage of medicines. We don't have money to take our child 
			abroad for treatment."
 
 Indian authorities delivered 25 tonnes of medical supplies, along 
			with other aid, on Sunday, officials said.
 
 "At no time has India assisted any other country to this extent ... 
			This is something for which we are deeply grateful," Sri Lanka's 
			foreign minister, G.L. Peiris, said at Colombo's port as he stood by 
			a vessel bringing in thousands of sacks of supplies.
 
 "This is probably the most difficult period that Sri Lanka has had 
			to face since independence."
 
 (Additional reporting by Devjyot Ghoshal; Writing by Raju 
			Gopalakrishnan; Editing by Robert Birsel)
 
			[© 2022 Thomson Reuters. All rights 
				reserved.]  This material may not be published, 
			broadcast, rewritten or redistributed.  
			Thompson Reuters is solely responsible for this content. 
			
			 |